Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-08-28

Clinical Trial Update: Prophylactic Effect of a CANDIDA Mouthwash, Containing the Curolox™ Peptide [NA]

View source ↗

Summary

A clinical trial evaluating a Candida mouthwash containing the Curolox peptide for dental erosion prophylaxis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curolox mouthwash (Curolox peptide mouthwash)

Snippet

Sponsor: Mibelle AG | Conditions: Erosion of Teeth, Unspecified | NA | Status: WITHDRAWN